These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9574346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK.
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Carcinoid tumors].
    Tóth M, Prónai L, Németh AM, Tulassay Z.
    Orv Hetil; 2002 May 12; 143(19 Suppl):1087-92. PubMed ID: 12063867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.
    Arch Surg; 2006 Oct 12; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
    Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S, Joehl RJ.
    Surgery; 2001 Oct 12; 130(4):677-82; discussion 682-5. PubMed ID: 11602899
    [Abstract] [Full Text] [Related]

  • 14. Carcinoid tumors of the gut. Our experience over three decades and review of the literature.
    Marshall JB, Bodnarchuk G.
    J Clin Gastroenterol; 1993 Mar 12; 16(2):123-9. PubMed ID: 8463615
    [Abstract] [Full Text] [Related]

  • 15. [Management of digestive system carcinoid tumors and carcinoid syndrome].
    Mondragón Sánchez RJ, Castillero Pinilla C, Saldívar Moreno C, Oñate Ocaña LF, Ruiz Molina JM, Aiello Crocifoglio V.
    Rev Gastroenterol Mex; 1998 Mar 12; 63(4):204-10. PubMed ID: 10319670
    [Abstract] [Full Text] [Related]

  • 16. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.
    Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, Brierley J, Siu LL.
    Am J Clin Oncol; 2008 Feb 12; 31(1):64-70. PubMed ID: 18376230
    [Abstract] [Full Text] [Related]

  • 17. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A, UKNETwork for Neuroendocrine Tumours.
    Gut; 2005 Jun 12; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L, Persson G, Franzén S, Ahrén B.
    Br J Surg; 2003 Jun 12; 90(6):687-93. PubMed ID: 12808615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.